Sanofi—Sanofi US Educational Grants

Sanofi US is committed to funding high quality educational activities and materials in the therapeutic areas of interest to the company that have the potential to improve patient care and health outcomes. The purpose of an educational grant is to support an activity that encourages an educational interchange with respect to available scientific and medical information. Educational activities may or may not be accredited.

Important to Note:

  • Educational grant requests must be submitted at least 12-16 weeks in advance of the request for notification date. Please utilize the notification date to ensure your grant is reviewed within the timeframe necessary for you to be able to disclose funding in a compliant fashion. The production start date is the date activity development begins, which will differ from the launch date.
  • Review and processing time will take approximately 6-8 weeks. Complete, accurate and detailed information is required to avoid delays. Applications with insufficient information may require additional processing time.
  • Please refer to the FAQ Section for Eligibility requirements, General Educational Request information, and the Fellowship Application Process prior to your educational grant request.

As of 1/3/2021

  • Sanofi US is currently accepting educational grant applications in the following therapeutic area(s):

    • US Cardiovascular, specific to the Area of Interest:
      • Diagnosis/Pharmacotherapeutic Management of Atrial Fibrillation
    • US and Global Multiple Sclerosis, specific to the Area of Interest:
      • Multiple Sclerosis
    • US and Global Neurology, specific to the Area of Interest:
      • Parkinson's disease with a GBA mutation
    • US Oncology, specific to the following Areas of Interest:
      • Prostate Cancer
      • Tumor Lysis
      • HSCT- stem cell mobilization and collection during autologous HSCT and Chemo
    • US and Global Rare Blood Disorder, specific to the Areas of Interest:
      • Hemophilia
      • Cold Agglutinin Disease (CAD)
      • Acquired Thrombotic Thrombocytopenic Purpura (aTTP)
    • US Rare Genetic Diseases, specific to the Areas of Interest:
      • Acid sphingomyelinase deficiency (ASMD)
      • Fabry Disease
      • Gaucher Disease
      • Pompe Disease
      • MPS1
      • Lysosomal Storage Disorders
      • Other Genetic Disorders
    • US Transplantation, specific to the Area of Interest:
      • Organ Transplant
  • The Sanofi-Regeneron Alliance is currently accepting educational grant submissions in the following therapeutic area(s):
    • US and Global Immunology, specific to the following Area(s) of Interest:
      • Atopic Dermatitis
    • US and Global Immunology/Respiratory, specific to the following Area of Interests, will be managed by Regeneron and should be submitted via https://mededgrants.regeneron.com starting December 2020:
      • Asthma
      • Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
      • Eosinophilic Esophagitis (EoE)
  • Sanofi US is not currently accepting educational grant applications in the following Therapeutic Areas:
    • US Immunology, specific to the Area of Interest:
      • Rheumatoid Arthritis
    • US Diabetes, specific to the Area of Interest:
      • Complementary insulin combinations to achieve HbA1c targets
      • Long Acting Insulins with a physiologic approach to glucose control
    • US Renal
    • US Osteoarthritis

Please take note of the following items:

  • Requests for Proposals (RFPs) are periodically placed on the Alliance for Continued Education in the Health Professions (ACEHP) and the Society for Academic Continuing Medical Education (SACME) websites.

Deadline: Undisclosed; registration required

Dollar Amount: Undisclosed; registration required

Eligibility:

Applicants must agree to the attestation to be eligible. Currently programs that involve a US Location or include US participants as a target audience or include US accreditation (e.g. ACCME, ACPE, ANCC) are eligible to receive an Educational Grant:

  • Accredited continuing education providers, health-related academic societies and organizations, medical education communication companies, teaching hospitals, educational institutions and other groups who have the potential to provide high quality education to advance healthcare are eligible to apply for an Educational Grant.
  • In order to avoid any conflict of interest, the company does not support Educational Grants to any of its customers, including HMOs, PPOs, GPOs, etc., or any doctor or group of doctors in private practice.

The only customers or potential customers that may be eligible for an Educational Grant are teaching hospitals and educational institutions whose mission includes public health education. Individuals are not eligible to receive educational grant funding. Applicants who have received past Educational Grant funding but have not provided budget reconciliation for the past activity (if activity end date was at least 90 days ago) are not eligible for funding.

Full RFPs (updated throughout the year): https://sgrants.envisionpharma.com/vt_sgrants/

 

Contact Us

Questions?  We're here to help. Contact us for assistance seeking or stewarding private funding.

Contact Us